High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain
Javier Crespo1,
, Moisés Diago2, Joaquín Cabezas1, Marina Berenguer3, Teresa Broquetas4, Miguel Ángel Serra5, Rosa Morillas6, Javier García-Samaniego7, José Luis Calleja8, Juan José Sánchez9, Sabela Lens10, Susana Soto-Fernández11, Begoña Sacristán12, Inmaculada Fernández13, Carmen López-Núñez14, María Buti15, Manuel Romero-Gómez16, Federico Sáez-Royuela17, Conrado Fernández18, Francisco Jorquera19..., Gloria Sánchez-Antolín20, Juan Manuel Pascasio21, Antonio Cuadrado22, Manuel Hernández-Guerra23, Spanish F2-Group Ver más
Corresponding author
1 Hospital Universitario Marqués de Valdecilla and IDIVAL. Santander. Spain
2 Hospital General Valencia. Spain
3 Hospital La Fé, University of Valencia and CIBERehd. Spain
4 Hospital Universitario del Mar. Barcelona. Spain
5 Hospital Clínico Universitario-Universidad de Valencia. Valencia. Spain
6 Hospital Universitario Trías y Pujol and CIBERehd. Badalona. Spain
7 Hospital Carlos III and CIBERehd. Madrid. Spain
8 Hospital Universitario Puerta Hierro. Madrid. Spain
9 Hospital Toledo. Spain
10 Hospital Clinic, IDIBAPS and CIBERehd. Barcelona. Spain
11 Hospital del Tajo, Aranjuez, Madrid. Spain
12 Hospital San Pedro, Logroño. Spain
13 Hospital 12 de Octubre. Madrid. Spain
14 Hospital Universitario Girona Dr. Josep Trueta. Spain
15 Hospital Universitario del Vall d’Hebrón and CIEBRehd. Barcelona. Spain
16 Hospital Universitario Valme and CIBERehd. Sevilla. Spain
17 Hospital Universitario de Burgos. Spain
18 Hospital Universitario de Alcorcón. Spain
19 Complejo Asistencial Universitario León. Spain
20 Hospital Universitario Rio Hortega. Valladolid. Spain
21 Hospital Universitario Virgen del Rocío. Sevilla. Spain
22 Hospital Comarcal de Laredo. Spain
23 Hospital Universitario de Canarias. Tenerife. Spain
Ver másRead
1189
Timeswas read the article
442
Total PDF
747
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 17 | 2 | 19 |
| 2024 October | 5 | 8 | 13 |
| 2024 September | 12 | 11 | 23 |
| 2024 August | 10 | 12 | 22 |
| 2024 July | 8 | 4 | 12 |
| 2024 June | 20 | 7 | 27 |
| 2024 May | 17 | 4 | 21 |
| 2024 April | 10 | 3 | 13 |
| 2024 March | 15 | 3 | 18 |
| 2024 February | 10 | 5 | 15 |
| 2024 January | 4 | 3 | 7 |
| 2023 December | 7 | 11 | 18 |
| 2023 November | 7 | 19 | 26 |
| 2023 October | 11 | 16 | 27 |
| 2023 September | 3 | 14 | 17 |
| 2023 August | 15 | 12 | 27 |
| 2023 July | 3 | 7 | 10 |
| 2023 June | 14 | 4 | 18 |
| 2023 May | 34 | 9 | 43 |
| 2023 April | 36 | 14 | 50 |
| 2023 March | 28 | 12 | 40 |
| 2023 February | 29 | 4 | 33 |
| 2023 January | 3 | 8 | 11 |
| 2022 December | 7 | 1 | 8 |
| 2022 November | 14 | 3 | 17 |
| 2022 October | 18 | 10 | 28 |
| 2022 September | 14 | 4 | 18 |
| 2022 August | 7 | 5 | 12 |
| 2022 July | 10 | 10 | 20 |
| 2022 June | 10 | 7 | 17 |
| 2022 May | 9 | 7 | 16 |
| 2022 April | 10 | 9 | 19 |
| 2022 March | 7 | 8 | 15 |
| 2022 February | 9 | 5 | 14 |
| 2022 January | 12 | 6 | 18 |
| 2021 December | 11 | 6 | 17 |
| 2021 November | 18 | 12 | 30 |
| 2021 October | 32 | 12 | 44 |
| 2021 September | 25 | 8 | 33 |
| 2021 August | 10 | 9 | 19 |
| 2021 July | 7 | 6 | 13 |
| 2021 June | 11 | 10 | 21 |
| 2021 May | 9 | 8 | 17 |
| 2021 April | 35 | 11 | 46 |
| 2021 March | 14 | 6 | 20 |
| 2021 February | 8 | 6 | 14 |
| 2021 January | 9 | 11 | 20 |
| 2020 December | 6 | 2 | 8 |
| 2020 November | 10 | 8 | 18 |
| 2020 October | 16 | 5 | 21 |
| 2020 September | 10 | 4 | 14 |
| 2020 August | 9 | 9 | 18 |
| 2020 July | 6 | 6 | 12 |
| 2020 June | 6 | 0 | 6 |
| 2020 May | 5 | 4 | 9 |
| 2020 April | 4 | 2 | 6 |
| 2020 March | 4 | 1 | 5 |
| 2020 February | 7 | 2 | 9 |
| 2020 January | 11 | 2 | 13 |
| 2019 December | 8 | 8 | 16 |
| 2019 November | 3 | 3 | 6 |
| 2019 October | 2 | 0 | 2 |
| 2019 September | 1 | 1 | 2 |
| 2019 August | 1 | 2 | 3 |
| 2019 July | 2 | 5 | 7 |
| 2019 June | 2 | 6 | 8 |
Show all
